{"id":"W3003499321","doi":"10.1200/jco.19.03022","title":"Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":455,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston General Hospital; Princess Margaret Cancer Centre; Queen's University; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Carboplatin; Medicine; Atezolizumab; Pembrolizumab; Pemetrexed; Bevacizumab; Oncology; Lung cancer; Internal medicine; Guideline; Crizotinib; Cancer; Chemotherapy; Cisplatin; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001943291,0.000161255,0.001148532,0.00005072112,0.00006230574,0.00002048813,0.0001186987,0.0002499828,0.0004756173],"category_scores_gemma":[0.0004421097,0.0001088542,0.0004411088,0.0000941457,0.0001439418,0.0001056286,0.0000315606,0.0005376455,0.000002605544],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009274861,"about_ca_system_score_gemma":0.00146574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003506532,"about_ca_topic_score_gemma":0.00005502491,"domain_scores_codex":[0.9969022,0.0001589609,0.002304294,0.0002284534,0.0001999723,0.000206144],"domain_scores_gemma":[0.9972441,0.0004143904,0.00137663,0.0001354668,0.0004988919,0.0003305631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.08604185,0.002003193,0.09597692,0.0003266523,0.003279499,0.0002958915,0.001345557,0.0001300158,0.07441249,0.00005643925,0.2025131,0.5336185],"study_design_scores_gemma":[0.04482719,0.01441536,0.03238003,0.0001408303,0.0005178953,0.00006389459,0.0001855883,0.005550113,0.003278334,0.00004452018,0.8983834,0.0002128181],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8944899,0.007585979,0.00910368,0.08642975,0.001135505,0.0008788746,0.00003008775,0.00001328544,0.0003329765],"genre_scores_gemma":[0.7424599,0.0552609,0.04953105,0.1445991,0.00655445,0.00005764974,0.0000211005,0.00007478531,0.001441102],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6958703,"threshold_uncertainty_score":0.5207676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.130242166794466,"score_gpt":0.4655758586952775,"score_spread":0.3353336919008114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}